Studies have shown that alterations in the Wnt/β-catenin, EGFR, TGF β and TP53 signalling pathways can affect CRC survival, proliferation and metastasis, and specific miRNAs can lead to changes in these signalling pathways, thereby promoting or inhibiting tumorigenesis (7). The gene discussed is TP53; the disease is colorectal carcinoma.